Acquisitions (Schedule Of Fair Values Of The Assets Acquired And Liabilities Assumed At The Acquisition Date) (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013	Feb. 28, 2014 Paladin Labs Inc. [Member]	Aug. 06, 2014 DAVA Pharmaceuticals, Inc [Member]	Feb. 28, 2014 Scenario, Previously Reported [Member] Paladin Labs Inc. [Member]	Feb. 28, 2014 Restatement Adjustment [Member] Paladin Labs Inc. [Member]
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Cash and cash equivalents			$ 113,571	$ 533	$ 113,571	$ 0
Marketable securities			89,420		89,420	0
Accounts receivable			97,094	15,842	93,832	3,262
Inventories			63,293	120,626	62,095	1,198
Prepaid expenses and other current assets			32,605	2,672	32,605	0
Deferred income tax assets, current			12,266		11,719	547
Property, plant and equipment			7,299	2,659	7,299	0
Intangible assets			650,248	439,623	676,000	(25,752)
Other assets			57,559	21,029	56,289	1,270
Total identifiable assets			1,123,355	602,984	1,142,830	(19,475)
Accounts payable and accrued expenses			128,257	17,585	124,321	3,936
Income taxes payable			23,458		22,524	934
Deferred income taxes			130,881	195,915	160,620	(29,739)
Debt			23,826		23,826	0
Other liabilities			9,715	21,139	9,578	137
Total liabilities assumed			316,137	234,639	340,869	(24,732)
Net identifiable assets acquired			807,218	368,345	801,961	5,257
Noncontrolling interests			(40,600)		(69,600)	29,000
Goodwill	3,804,959	1,372,832	2,100,308	226,683	2,134,565	(34,257)
Net assets acquired			$ 2,866,926	$ 595,028	$ 2,866,926	$ 0